Remember when the market soared on several days in April on the Facui-touted Remdesivir study which, according to StatNews and various other unofficial sources of rumors, was a smashing success only for the optimism to fizzle as many questions emerged, and as the Gilead drug quietly faded from the public's consciousness and was replaced by various coronavirus vaccine candidates such as those made by the greatly hyped Moderna (whose insiders just can't stop selling company stock).

Meanwhile, those who were waiting for the official version of Remdesivir's effectiveness had to do so until 6pm on a Friday before a long holiday, and for good reason...